Breast health

BI-RADS 4: Suspicious Finding, Wide Range of Odds

Save

A BI-RADS 4 mammogram is a suspicious finding that leads to a biopsy, but the odds vary widely. In the radiology BI-RADS system, category 4 means roughly a 2 to 95 percent chance of cancer, split into 4A, 4B, and 4C. Most turn out benign, and the biopsy settles it.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What does BI-RADS 4 mean?

A BI-RADS 4 assessment means imaging found something suspicious enough to recommend a biopsy. BI-RADS is a standardized scoring system from the American College of Radiology that sorts breast imaging into categories from 0 to 6, and category 4 is the 'suspicious' tier that sits between probably benign and highly suggestive of cancer 1. A score of 4 does not mean you have cancer; it means the finding cannot be called benign on imaging alone. According to the National Cancer Institute, most abnormal screening results are not cancer, and further testing sorts out which findings are 2. The recommended next step for category 4 is a tissue sample.

How likely is BI-RADS 4 to be cancer?

Category 4 covers a wide probability range, from about 2 percent to 95 percent chance of cancer. That span is exactly why a single number cannot capture how concerning a given finding is — a 4 can be a low-suspicion result or a fairly worrying one, and only a biopsy resolves it. Most category 4 findings, taken together, turn out benign 1. For context, about 13 in 100 women develop breast cancer over a lifetime 3, and a category 4 result raises the odds for that specific finding without confirming anything. The wide range is not vagueness; it is why radiologists break the category into subgroups. Your radiologist assigns the category from the specific features of the finding, such as its shape, margins, and any change from prior images 1.

What is the difference between 4A, 4B, and 4C?

Radiologists split category 4 into three tiers to signal how suspicious a finding looks. In the American College of Radiology's BI-RADS system, 4A carries a low suspicion of cancer (roughly a 2 to 10 percent chance), 4B a moderate suspicion (about 10 to 50 percent), and 4C a high suspicion (about 50 to 95 percent). All three still lead to the same next step — a biopsy — because imaging alone cannot rule cancer in or out. Knowing your subcategory can help you gauge the odds and frame questions for your clinician, but a 4A finding is far more likely to be benign than a 4C one.

What happens at a breast biopsy?

A breast biopsy removes a small tissue sample so a pathologist can check the finding under a microscope. Most are core-needle biopsies done with local numbing and imaging guidance, often in under an hour, with results in a few days to a week 1. The mix of category 4 findings shifts across life stages: denser breasts in younger and perimenopausal women can produce more indeterminate results, while postmenopausal changes can also look suspicious on imaging 12. Whatever the biopsy shows, having the answer is what allows a clear plan, and delaying rarely changes the outcome for a truly benign finding. You can read about when to start mammograms to understand the screening path that led here, along with the broader cancer screenings by age.

When a BI-RADS 4 result needs prompt scheduling

A BI-RADS 4 result is a reason to schedule the recommended biopsy soon, not to panic. Booking the biopsy promptly, asking your clinician for the 4A/4B/4C subcategory, and bringing your family history all help 1. A breast lump you can feel alongside the imaging finding, or a strong family history, is a reason to seek clinician review without long delay 23. If your mammogram was otherwise clear but you still feel a lump, that is worth raising too. Learning how to check your breasts can help you track changes while you wait for results. Gale can help you prepare for that conversation and keep your questions in one place.

Common questions

No. BI-RADS 4 means a finding is suspicious enough to biopsy, not that cancer is confirmed. The category spans a wide range of odds, from about 2 to 95 percent, and most category 4 findings turn out benign.

They signal how suspicious the finding looks. 4A is low suspicion, 4B moderate, and 4C high. All three lead to a biopsy because imaging alone cannot confirm or rule out cancer, but the subgroup helps set expectations.

A biopsy for a BI-RADS 4 finding is usually scheduled within days to a couple of weeks. It is important but not an emergency. Ask your clinician about timing and what type of biopsy is planned.

Core-needle biopsy results usually come back within a few days to about a week. Ask how and when you will get them, and whether a follow-up visit is arranged to discuss the plan.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a BI-RADS 4 result needs a clinician

  • —A recommended biopsy that has not been scheduled is a reason to contact your clinician to book it soon.
  • —A palpable lump alongside the BI-RADS 4 imaging finding is a reason to seek prompt clinician review.
  • —A strong family history of breast or ovarian cancer is a reason to ask a clinician about genetic counseling and added imaging.
  • —New skin dimpling, nipple retraction, or bloody discharge is a reason to seek clinician evaluation without delay.

This article is general health education, not medical advice. A BI-RADS 4 result and its biopsy plan should be discussed with the radiologist and a breast specialist or primary care clinician who can review your images and history.

References

  1. 1.American College of Obstetricians and Gynecologists (2017). Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002158 ✓Structured reporting of breast imaging assessment categories and follow-up; a suspicious finding is worked up with tissue biopsy under imaging guidance.
  2. 2.National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025). Breast Cancer Screening. National Cancer Institute (NCI), NIH. link ✓Most abnormal screening results are not cancer, and further diagnostic testing determines which findings require treatment.
  3. 3.National Cancer Institute (2024). BRCA Gene Changes: Cancer Risk and Genetic Testing Fact Sheet. National Cancer Institute (NCI), NIH. link ✓General-population lifetime breast cancer risk of about 13 percent (1 in 8) and higher risk with family history, giving context to an individual suspicious finding.

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library